Serum Lipoprotein (a) Levels in Patients with Chronic Renal Failure – Evolution after Renal Transplantation and Relationship with Other Parameters of Lipoprotein Metabolism: A Prospective Study

Nephron ◽  
1995 ◽  
Vol 69 (1) ◽  
pp. 9-13 ◽  
Author(s):  
A. Segarra ◽  
P. Chacón ◽  
M. Martin ◽  
M. Vilardell ◽  
J. Vila ◽  
...  
1994 ◽  
Vol 14 (3) ◽  
pp. 236-239 ◽  
Author(s):  
Edward C. Kohaut ◽  
F. Bryson Waldo ◽  
Mark R. Benfield

Objectives To determine the effect of changing dialysate volume on urea and glucoseequilibration curves and to determine, if dialysate volume is prescribed on the basis of body surface area, whether equilibration curves will be consistent in patients of different sizes and ages. Design A prospective study wherein children with acute or chronic renal failure had peritoneal equilibration studies done with dwell volumes of 30 mL/kg, 40 mL/kg, and 1200 mL/m2. Patient Population Twenty-two children: 7 under 3 years of age; 8 between 3 and 10 years of age; 7 older than 10 years of age. Statistics Student's t-test. Results Urea and glucose equilibrated rapidly at dwell volumes of 30 mL/kg, slower at dwell volumes of 40 mL/kg, and slowest at dwell volumes of 1200 mL/m2. Equilibration curves were similar in children of different ages when dialysate volumes of 1200 mL/m2 were infused. Conclusion Dialysate volumes of 1200 mL/m2 should be used when equilibration studies are being done to compare individuals of different ages and sizes.


1997 ◽  
Vol 38 (1) ◽  
pp. 83-89 ◽  
Author(s):  
M. Ramazan YIGITOGLU ◽  
M. Fevzi POLAT ◽  
Fatih AKÇAY ◽  
Zeki ARI ◽  
B. Sami UYANIK ◽  
...  

2019 ◽  
Vol 289 ◽  
pp. 8-13
Author(s):  
Jie Zhang ◽  
Rui Du ◽  
Kui Peng ◽  
Xueyan Wu ◽  
Chunyan Hu ◽  
...  

2000 ◽  
Vol 98 (s42) ◽  
pp. 10P-10P
Author(s):  
NM Al-Saady ◽  
KM Sharobeem ◽  
JA Kwan ◽  
JB Eastwood ◽  
S Snowden ◽  
...  

1999 ◽  
Vol 15 (4) ◽  
pp. 237-247 ◽  
Author(s):  
Essam Mady ◽  
Gehane Wissa ◽  
Ali Khalifa ◽  
Mahmoud El-Sabbagh

This study was carried out to investigate the relationship between lipoprotein (a) levels and the development of atherosclerosis in chronic renal failure (CRF) patients with the possible role of the liver. Serum Lp (a) levels were measured in samples from 20 CRF patients on hemodialysis (HD), 20 liver cirrhosis (LC) patients, 20 patients having both CRF and LC and undergoing HD, and 20 normal control subjects. Renal function (blood urea nitrogen (BUN) and creatinine), hepatic function (transaminases (ALT and AST), alkaline phosphatase (ALP) and total bilirubin) investigations and serum cholesterol were carried out for all the subjects enrolled in this study. Serum Lp (a) concentration in CRF patients without LC was 87.25 ± 6.17 mg/dl, which was significantly higher than all the investigated groups (P < 0.001). Lp(a) concentration in patients with both CRF and LC was 24.65 ± 1.98 mg/dl, which was not significantly different from the controls, but was significantly higher than that in the subjects with LC only (P < 0.001) where the latter group had significantly low Lp (a) values (11.1 ± 0.99) relative to all the other groups (P < 0.001). Lp (a) correlated positively with cholesterol in all groups except the LC subjects, but did not correlate with age, or renal function in both CRF groups.


Sign in / Sign up

Export Citation Format

Share Document